Coastal Investment Advisors, Inc. Aerie Pharmaceuticals Inc Transaction History

Coastal Investment Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 01, 2019	SELL	$28.97 - $48.21 $19,844 - $33,023	-685 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $24,879 - $33,736	685 New	685 $33,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.